Galderma Offers $978M For Sweden's Q-Med
Skin care company Galderma Pharma SA, a Nestle SA and L'Oreal joint venture, has offered roughly 6.69 billion Swedish kronor ($978 million) for Swedish implant maker Q-Med AB....To view the full article, register now.
Already a subscriber? Click here to view full article